Description

Medogystin (betahistine dihydrochloride) tablets 16 mg. №30

Ingredients

Active ingredient: Betahistine dihydrochloride 16 mg per tablet.

Dosage

Recommended dosage: The usual dose is 16 mg three times a day with meals.

Indications

Medogystin tablets are indicated for the treatment of Meniere’s disease and vertigo associated with vestibular disorders.

Contraindications

Do not use Medogystin tablets if you are allergic to betahistine or any other ingredients in the product. Consult your healthcare provider before use if you are pregnant or breastfeeding.

Directions

Take Medogystin tablets orally with a glass of water. Do not crush or chew the tablets. Follow the dosage instructions provided by your healthcare provider.

Scientific Evidence

Betahistine, the active ingredient in Medogystin tablets, is known to improve inner ear circulation and reduce the frequency and severity of vertigo attacks. Studies have shown that betahistine can effectively alleviate symptoms of Meniere’s disease by enhancing cochlear and vestibular blood flow.

Additional Information

It is important to note that individual responses to medication may vary. If you experience any adverse effects or have concerns about taking Medogystin tablets, consult your healthcare provider for further guidance.

Pharmacological Effects: Betahistine acts as a histamine H3 receptor agonist and H1 receptor antagonist, leading to increased cochlear and cerebral blood flow. This mechanism helps in reducing the frequency and intensity of vertigo attacks.

Clinical Trials: Clinical trials have demonstrated the efficacy of betahistine in improving symptoms of vertigo and Meniere’s disease. A study by Strupp et al. (2016) showed a significant reduction in vertigo attacks and improved quality of life in patients treated with betahistine.